Increased incidence of carcinoma of the tongue in patients with systemic sclerosis

Journal of Rheumatology

Volumn 32, Issue 4, 2005, Pages 637-641

  Derk, Chris T ^a,c   Rasheed, Mehmoodur ^a,b   Spiegel, Joseph R ^a   Jimenez, Sergio A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Holzer Clinic   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Oral cavity cancer; Squamous cell carcinoma; Systemic sclerosis; Tissue fibrosis; Tongue cancer

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; PENICILLAMINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MOUTH CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCLERODERMA; SQUAMOUS CELL CARCINOMA; SYSTEMIC SCLEROSIS; TONGUE CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PENNSYLVANIA; SCLERODERMA, SYSTEMIC; TONGUE NEOPLASMS;

EID: 17144388265     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Roumm AD, Medsger TA Jr. Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum 1985;28:1336-40.
2. Abu Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-4.
3. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993;52:531-3.
4. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-4.
5. Hill CL, Nguyen AM, Roder D, Roberts-Thompson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728-31.
6. Chatterjee S, Severson RK, Weiss LK, Kau TY, Mayes MD. Risk of malignancy in scleroderma [abstract]. Arthritis Rheum 2000;43 Suppl:S315.
7. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer Statistics, 2003. CA Cancer J Clin 2003;53:5-26.
8. Das BR, Nagpal JK. Understanding the biology of oral cancer. Med Sci Monit 2002;8:258-67.
9. Elamin F, Steingrimsdottir H, Warnakulasuriya S, Johnson N, Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in UK subjects: a novel method of detection. Oral Oncol 1998;34:191-7.
10. Mao EJ, Smith CJ. Detection of Epstein-Barr virus DNA by polymerase chain reaction in oral smears from healthy individuals and patients with squamous cell carcinoma. J Oral Pathol Med 1993;22:12-7.
11. Zain RB, Ikeda N, Gupta PC, et al. Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. J Oral Pathol Med 1999;28:1-4.
12. Lally EV, Jimenez SA, Kaplan SR. Progressive systemic sclerosis: Mode of presentation, rapidly progressive disease course, and mortality based on analysis of 91 patients. Semin Arthritis Rheum 1988;18:1-13.
13. Jimenez SA, Sigal SH. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine. J Rheumatol 1991;18:1496-503.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980:23:581-90.
15. Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Public-Use, Nov. 2002 Sub (1973-2000). Washington, DC: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2003, based on the November 2002 submission. Available from: www.seer.cancer.gov. Accessed December 31, 2004.
16. Breslow NE, Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort studies. IARC Sci Publ 1987;82:1-406.
17. Kahan A, Gerfaux J, Kahan A, Joret A, Menkes CJ, Amor B. Increased proto-oncogene expression in peripheral blood T lymphocytes from patients with systemic sclerosis. Arthritis Rheum 1989;32:430-6.
18. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
19. Nietert PJ, Silver RM. Systemic sclerosis: environmental and occupational risk factors. Curr Opin Rheumatol 2000;12:520-6.
20. Ward E, Boffetta P, Andersen A, et al. Update of the follow-up of mortality and cancer incidence among European workers employed in the vinyl chloride industry. Epidemiology 2001;12:710-8.
21. Warnakulasuriya S, Trivedy C, Peters TJ. Areca nut use: an independent risk factor for oral cancer. BMJ 2002;324:799-800.
22. Vaughan TL, Steward PA, Davis S, Thomas DB. Work in dry cleaning and the incidence of cancer of the oral cavity, larynx, and oesophagus. Occup Environ Med 1997;54:692-5.
23. Czirjak L, Pocs E, Szegedi G. Localized scleroderma after exposure to organic solvents. Dermatology 1994;189:399-401.
24. Chang CH, Wang YM, Yang AH, et al. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001;21:441-8.
25. Li X, Wang H. Aristolochic acid nephropathy: what we know and what we have to do. Nephrology 2004;9:109-11.
26. Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004;140:37-50.